CST
MRK icon

Charles Schwab Trust’s Merck MRK Stock Holding History

Charles Schwab Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
8,250
+330
+4% +$38.6K 0.06% 101
2026
Q1 		$953K Sell
7,920
-694
-8% -$80.1K 0.06% 92
2025
Q4 		$907K Sell
8,614
-226
-3% -$21.2K 0.06% 94
2025
Q3 		$742K Buy
8,840
+386
+5% +$31.8K 0.05% 100
2025
Q2 		$669K Hold
8,454
– – 0.05% 101
2025
Q1 		$759K Sell
8,454
-3,360
-28% -$314K 0.06% 96
2024
Q4 		$1.18M Buy
11,814
+1,178
+11% +$121K 0.1% 79
2024
Q3 		$1.21M Sell
10,636
-3,296
-24% -$392K 0.1% 76
2024
Q2 		$1.72M Buy
13,932
+973
+8% +$125K 0.16% 67
2024
Q1 		$1.71M Sell
12,959
-2,303
-15% -$284K 0.16% 67
2023
Q4 		$1.66M Sell
15,262
-220
-1% -$22.8K 0.16% 69
2023
Q3 		$1.59M Buy
15,482
+1,313
+9% +$142K 0.18% 67
2023
Q2 		$1.56M Buy
14,169
+6
+0% +$681 0.19% 57
2023
Q1 		$1.51M Buy
14,163
+1,010
+8% +$109K 0.18% 59
2022
Q4 		$1.46M Buy
13,153
+3,421
+35% +$350K 0.19% 60
2022
Q3 		$838K Sell
9,732
-85
-0.9% -$7.59K 0.14% 80
2022
Q2 		$895K Buy
9,817
+1
+0% +$89 0.19% 71
2022
Q1 		$805K Buy
9,816
+326
+3% +$25.7K 0.14% 82
2021
Q4 		$727K Sell
9,490
-269
-3% -$21.4K 0.12% 95
2021
Q3 		$733K Sell
9,759
-486
-5% -$37K 0.14% 103
2021
Q2 		$797K Sell
10,245
-754
-7% -$56.1K 0.16% 93
2021
Q1 		$809K Sell
10,999
-3,756
-25% -$277K 0.17% 92
2020
Q4 		$1.15M Buy
14,755
+786
+6% +$60.1K 0.28% 74
2020
Q3 		$1.11M Buy
13,969
+197
+1% +$15.4K 0.34% 59
2020
Q2 		$1.01M Sell
13,772
-178
-1% -$13.4K 0.34% 64
2020
Q1 		$1.02M Buy
13,950
+340
+2% +$26.7K 0.42% 60
2019
Q4 		$1.18M Buy
13,610
+1,308
+11% +$107K 0.46% 57
2019
Q3 		$981K Buy
+12,302
New +$986K 0.46% 57

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Charles Schwab Trust's MRK Position: Q2 2026 in Review

Charles Schwab Trust increased its Merck (MRK) stake by 4.2% in Q2 2026, buying an estimated $38.6K and bringing the position to 8,250 shares worth $1.06M. The position accounts for 0.06% of the portfolio, ranked #101.

Charles Schwab Trust first reported a position in MRK in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.72M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Charles Schwab Trust held 8,250 shares of Merck worth $1.06M as of Q2 2026.
  • Charles Schwab Trust bought 330 Merck shares in Q2 2026, an estimated $38.6K.
  • Merck made up 0.06% of Charles Schwab Trust's portfolio in Q2 2026, its #101 holding.
  • Charles Schwab Trust first reported a position in Merck in Q3 2019 and has held it in 28 quarters since.
  • Charles Schwab Trust's Merck position peaked at $1.72M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.